Literature DB >> 18840073

Epigenetic changes in cancer.

Christine A Iacobuzio-Donahue1.   

Abstract

Cancer is as much an epigenetic disease as it is a genetic disease, and epigenetic alterations in cancer often serve as potent surrogates for genetic mutations. Normal epigenetic modifications of DNA encompass three types of changes: chromatin modifications, DNA methylation, and genomic imprinting, each of which is altered in cancer cells. This review addresses the various epigenetic modifications that are pervasive among human tumors and traces the history of cancer epigenetics from the first observations of altered global methylation content to the recently proposed epigenetic progenitor model, which provides a common unifying mechanism for cancer development.

Entities:  

Mesh:

Year:  2009        PMID: 18840073     DOI: 10.1146/annurev.pathol.3.121806.151442

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  60 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

2.  Insights into the role of DNA methylation in disease through the use of mouse models.

Authors:  Melissa Conerly; William M Grady
Journal:  Dis Model Mech       Date:  2010 May-Jun       Impact factor: 5.758

3.  The evolution of epitype.

Authors:  Richard B Meagher
Journal:  Plant Cell       Date:  2010-06-15       Impact factor: 11.277

Review 4.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

Review 5.  Epigenetics and cancer.

Authors:  Rajnee Kanwal; Sanjay Gupta
Journal:  J Appl Physiol (1985)       Date:  2010-03-04

Review 6.  Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics.

Authors:  Craig D Logsdon; Thiruvengadam Arumugam; Vijaya Ramachandran
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-09       Impact factor: 4.052

7.  Histone modifications and cancer: biomarkers of prognosis?

Authors:  Yana Chervona; Max Costa
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

Review 8.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

9.  Identification of methylated genes associated with aggressive bladder cancer.

Authors:  Carmen J Marsit; E Andres Houseman; Brock C Christensen; Luc Gagne; Margaret R Wrensch; Heather H Nelson; Joseph Wiemels; Shichun Zheng; John K Wiencke; Angeline S Andrew; Alan R Schned; Margaret R Karagas; Karl T Kelsey
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

10.  Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells.

Authors:  Kiran Kumar Velpula; Venkateswara Rao Gogineni; Arun Kumar Nalla; Dzung H Dinh; Jasti S Rao
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.